Syncona Ltd (LON:SYNC), a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life sciences, has announced the appointment of Virginia Holmes as a Non-Executive Director with effect from 1 January 2021.
Virginia has extensive knowledge of the financial services industry including investment management and banking. She was previously Chief Executive of AXA Investment Managers UK and held a number of senior leadership roles over more than a decade at Barclays Bank Group.
Virginia also brings a wide range of Board experience, both with UK listed companies and organisations across various jurisdictions. She is currently a Non-Executive Director of Intermediate Capital Group plc, a FTSE 100 specialist asset manager, and of the European Opportunities Trust plc, a closed ended European equity fund. She is also Chair of USS Investment Management Ltd, the fiduciary manager of Universities Superannuation Scheme Ltd.
Melanie Gee, Chair of Syncona Limited, said: “We are pleased to strengthen our Board of Directors with the appointment of Virginia. She has extensive experience and a proven track record of working with investment businesses as they look to develop and expand. Her expertise will be invaluable as we look to manage and grow a sustainable portfolio of leading life science companies.”
Virginia Holmes said: “I am very much looking forward to joining Syncona’s Board and working with their expert life science investment team, to support them in accelerating the growth of the business and delivering the purpose to invest to extend and enhance human life.”
